Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-060301
Filing Date
2025-04-29
Accepted
2025-04-29 17:00:21
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A wve-20241231.htm   iXBRL 10-K/A 1977210
2 EX-31.1 wve-ex31_1.htm EX-31.1 8454
3 EX-31.2 wve-ex31_2.htm EX-31.2 9473
  Complete submission text file 0000950170-25-060301.txt   2449901

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT wve-20241231.xsd EX-101.SCH 61935
18 EXTRACTED XBRL INSTANCE DOCUMENT wve-20241231_htm.xml XML 18913
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37627 | Film No.: 25888946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)